FMP
FATE icon

Financial Management Professionals’s Fate Therapeutics FATE Stock Holding History

Financial Management Professionals’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,000
Closed -$20K – 310
2019
Q2 		$20K Buy
+1,000
New +$18K 0.01% 147

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
GH
Grosvenor Holdings Chicago, Illinois $512M AUM 19.57% 1-Year Est. Return

Financial Management Professionals's FATE Position: Q3 2019 in Review

Financial Management Professionals sold out of Fate Therapeutics (FATE) in Q3 2019, closing a stake of 1,000 shares — an estimated $20K sold.

Financial Management Professionals first reported a position in FATE in Q2 2019 and held it in 1 quarter. The position peaked at $20K in Q2 2019. 149 funds tracked by Wall St. Rank hold FATE as of Q3 2019.

  • Financial Management Professionals reported no remaining Fate Therapeutics position as of Q3 2019 after selling out during the quarter.
  • Financial Management Professionals sold 1,000 Fate Therapeutics shares in Q3 2019, an estimated $20K.
  • Financial Management Professionals first reported a position in Fate Therapeutics in Q2 2019 and held it in 1 quarter.
  • Financial Management Professionals's Fate Therapeutics position peaked at $20K in Q2 2019.
  • 149 funds tracked by Wall St. Rank held Fate Therapeutics as of Q3 2019.

Based on Financial Management Professionals's 13F filing for Q3 2019, filed 11 Oct 2019.